Multiple system atrophy (MSA) is clinically characterised by varying combination of parkinsonism, pyramidal signs, and progressive autonomic failure, and/or cerebellar ataxia; it is also pathologically characterised by the abnormal accumulation of alpha-synuclein in oligodendrocytes [106, 107]. This evidence concerns the gene SNCA and Parkinson disease.